Department of Parasitology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Laboratory of Cell-Cell Interactions, Department of Morphology, Universidade Federal de Minas Gerais, Belo Horizonte,Brazil.
Vaccine. 2024 Aug 30;42(21):126141. doi: 10.1016/j.vaccine.2024.07.042. Epub 2024 Jul 20.
Amblyomma sculptum is widely distributed in Brazil and is the main vector of Rickettsia rickettsii, the causative agent of the Brazilian spotted fever (BSF). Tick gut proteins play an essential role in blood feeding, digestion, and protection of gut epithelium. Therefore, many of these were investigated as potential vaccine targets for tick-control strategies. The present study aimed to select transcripts corresponding to putative immunogenic proteins in the A. sculptum gut epithelial membrane, produce recombinant proteins and evaluate them as antigens against A. sculptum infestations. Three gut proteins - AsMucin, AsAPP, and AsLAMP - and a chimeric protein (rAsChimera) based on 22 peptides containing putative B cell epitopes from seven different gut proteins were evaluated as anti-A. sculptum antigens. Mice immunizations revealed that all recombinant targets elicited humoral response with significantly increased IgG levels compared to controls. For rAsChimera, IgG levels remained significantly higher than controls up to 75 days after the end of the immunization. Challenge trials revealed that vaccination with the chimeric protein was the most effective against A. sculptum, inducing 100 % nymph mortality and reaching 80.8 % efficacy against females. The other three proteins did not induce relevant protection, as AsAPP had only 26.6 % efficacy, whereas AsMucin and AsLAMP induced no protection. These data indicate that targeting gut protein immunogenic regions may be an effective strategy for a vaccine formulation againstA. sculptum.
刻花盲蛛广泛分布于巴西,是导致巴西斑疹热(BSF)的立克次体的主要传播媒介。蜱肠道蛋白在吸血、消化和保护肠道上皮中起着至关重要的作用。因此,许多研究都将这些蛋白作为潜在的疫苗靶点,用于控制蜱的策略。本研究旨在选择在 A. 雕刻肠道上皮膜中对应的假定免疫原性蛋白的转录本,生产重组蛋白并评估其作为针对 A. 雕刻的抗寄生虫感染的抗原。三种肠道蛋白(AsMucin、AsAPP 和 AsLAMP)和一种基于来自七种不同肠道蛋白的 22 个肽的嵌合蛋白(rAsChimera)被评估为抗 A. 雕刻的抗原。免疫小鼠显示,所有重组靶标均引起体液免疫反应,与对照组相比 IgG 水平显著升高。对于 rAsChimera,IgG 水平在免疫结束后 75 天内仍显著高于对照组。挑战试验表明,用嵌合蛋白进行疫苗接种对 A. 雕刻最有效,诱导 100%的若虫死亡率,对雌性的有效性达到 80.8%。其他三种蛋白未引起相关保护,因为 AsAPP 的有效性仅为 26.6%,而 AsMucin 和 AsLAMP 则没有保护作用。这些数据表明,针对肠道蛋白免疫原性区域可能是针对 A. 雕刻的疫苗制剂的有效策略。